Gefitinib therapy for non-small cell lung cancer
A Birnbaum, N Ready - Current Treatment Options in Oncology, 2005 - Springer
… Iressa dose evaluation for advanced lung cancer phase II trials (IDEAL 1 and IDEAL 2) of
single agent gefitinib… day in pretreated patients with non-small cell lung cancer (NSCLC), found …
single agent gefitinib… day in pretreated patients with non-small cell lung cancer (NSCLC), found …
Gefitinib for non-small-cell lung cancer treatment
A D'Incecco, F Cappuzzo - Expert opinion on drug safety, 2011 - Taylor & Francis
… of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor
mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403). Br J Cancer …
mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403). Br J Cancer …
Overview of gefitinib in non-small cell lung cancer: an Asian perspective
H Jiang - Japanese journal of clinical oncology, 2009 - academic.oup.com
… patients who receive gefitinib first-line, outcome from gefitinib therapy in patients who had
… was equally longer with both gefitinib and docetaxel treatments in EGFR mutation-positive (…
… was equally longer with both gefitinib and docetaxel treatments in EGFR mutation-positive (…
Gefitinib Therapy for Advanced Non–Small-Cell Lung Cancer
CY Liu, S Seen - Annals of Pharmacotherapy, 2003 - journals.sagepub.com
… All published trials and abstracts citing gefitinib were … Gefitinib is a selective EGFR tyrosine
kinase inhibitor. Based on the … Recent trials have shown that gefitinib provided a 10% tumor …
kinase inhibitor. Based on the … Recent trials have shown that gefitinib provided a 10% tumor …
Practical management of patients with non–small-cell lung cancer treated with gefitinib
NT Shah, MG Kris, W Pao, LB Tyson… - Journal of Clinical …, 2005 - ascopubs.org
… in persons with lung cancer. Many of the principles of management relevant to gefitinib are
distinct … practical guidelines on the use of gefitinib in patients with non–small-cell lung cancer. …
distinct … practical guidelines on the use of gefitinib in patients with non–small-cell lung cancer. …
Gefitinib Induces Apoptosis in the EGFRL858R Non–Small-Cell Lung Cancer Cell Line H3255
S Tracy, T Mukohara, M Hansen, M Meyerson… - Cancer research, 2004 - AACR
… in patients with non–small-cell lung cancer (… gefitinib. One of these mutations, L858R (Leu→Arg),
is also found in NSCLC cell line H3255, which is very sensitive to gefitinib treatment…
is also found in NSCLC cell line H3255, which is very sensitive to gefitinib treatment…
Gefitinib in non small cell lung cancer
R Costanzo, MC Piccirillo… - BioMed Research …, 2011 - Wiley Online Library
… In the second study, including 88 patients in Europe and Australia, gefitinib was … with either
advanced non small cell lung, ovarian, head and neck, prostate, or colorectal cancer [11]. At …
advanced non small cell lung, ovarian, head and neck, prostate, or colorectal cancer [11]. At …
Safety of gefitinib in non-small cell lung cancer treatment
EHC Hsiue, JH Lee, CC Lin… - Expert opinion on drug …, 2016 - Taylor & Francis
… , gefitinib adds to the list of recommended first-line treatments for lung cancer harboring EGFR
… , clinical efficacy, and safety of gefitinib in major clinical trials and post-marketing studies. …
… , clinical efficacy, and safety of gefitinib in major clinical trials and post-marketing studies. …
Gefitinib for the treatment of non-small-cell lung cancer
T Hida, S Ogawa, JC Park, JY Park… - … of anticancer therapy, 2009 - Taylor & Francis
… Gefitinib is an orally bioavailable, EGF receptor tyrosine kinase inhibitor and was the first …
non-small-cell lung cancer (NSCLC). Identification of objective tumor regressions with gefitinib …
non-small-cell lung cancer (NSCLC). Identification of objective tumor regressions with gefitinib …
Gefitinib or chemotherapy for non–small-cell lung cancer with mutated EGFR
M Maemondo, A Inoue, K Kobayashi… - New England journal …, 2010 - Mass Medical Soc
… studies of gefitinib therapy in patients with advanced non–small-cell lung cancer and
EGFR … We then undertook a phase 3 study comparing gefitinib and standard carboplatin–paclitaxel …
EGFR … We then undertook a phase 3 study comparing gefitinib and standard carboplatin–paclitaxel …